- Home
- IAE vs SER Comparison
IAE vs SER Comparison
Compare IAE & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IAE
- SER
- Stock Information
- Founded
- IAE 2007
- SER 2017
- Country
- IAE United States
- SER United States
- Employees
- IAE N/A
- SER N/A
- Industry
- IAE Trusts Except Educational Religious and Charitable
- SER Biotechnology: Pharmaceutical Preparations
- Sector
- IAE Finance
- SER Health Care
- Exchange
- IAE Nasdaq
- SER Nasdaq
- Market Cap
- IAE 65.2M
- SER 53.5M
- IPO Year
- IAE N/A
- SER 2018
- Fundamental
- Price
- IAE $6.30
- SER $5.63
- Analyst Decision
- IAE
- SER Strong Buy
- Analyst Count
- IAE 0
- SER 1
- Target Price
- IAE N/A
- SER $11.00
- AVG Volume (30 Days)
- IAE 46.3K
- SER 12.0K
- Earning Date
- IAE 01-01-0001
- SER 05-24-2025
- Dividend Yield
- IAE 10.21%
- SER N/A
- EPS Growth
- IAE N/A
- SER N/A
- EPS
- IAE N/A
- SER N/A
- Revenue
- IAE N/A
- SER $56,000.00
- Revenue This Year
- IAE N/A
- SER N/A
- Revenue Next Year
- IAE N/A
- SER N/A
- P/E Ratio
- IAE N/A
- SER N/A
- Revenue Growth
- IAE N/A
- SER N/A
- 52 Week Low
- IAE $5.31
- SER $3.81
- 52 Week High
- IAE $6.45
- SER $14.57
- Technical
- Relative Strength Index (RSI)
- IAE 61.98
- SER 54.32
- Support Level
- IAE $6.19
- SER $5.64
- Resistance Level
- IAE $6.33
- SER $6.61
- Average True Range (ATR)
- IAE 0.08
- SER 0.48
- MACD
- IAE 0.03
- SER -0.02
- Stochastic Oscillator
- IAE 90.24
- SER 53.51
About IAE Voya Asia Pacific High Dividend Equity Income Fund ING Asia Pacific High Dividend Equity Income Fund of Beneficial Interest
Voya Asia Pacific High Dividend Equity Income Fund is a United States-based diversified, closed-end fund.The investment objective of the fund is to provide a total return through a combination of current income, capital gains, and capital appreciation. To achieve this objective, under normal market conditions, the fund invests in a portfolio of dividend-yielding equity securities of companies located in the Asia Pacific region.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.